Frontlight ResearchEarly access
Chronic lymphocytic leukaemia trials in United States
153 of 184 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleEfficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- Where
- Dallas, Denver, East Brunswick, Fargo, Hackensack, La Jolla, Louisville, Rochester, Spokane, Springdale, Torrance
- Age
- 18 years and over
- People
- 490 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04728893 · EU 2023-504931-42-00 - No phaseTaking peopleImplanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors
- Where
- New Hyde Park
- Age
- 18 years and over
- People
- 50
- Run by
- Northwell Health
See details and how to joinNCT05643235 - Phase 3Taking peopleA Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
- Where
- Aberdeen, Albany, Bethesda, Billings, Charlottesville, Clermont, Fort Wayne, Hattiesburg, Kansas City, Long Beach, Madison, Marshall, Mitchell, Morgantown, Morristown, Olympia, Pembroke Pines, Pierre, Portland, Reno, Sioux Falls, Spokane, Springdale, Sugar Land, Yankton
- Age
- 18 years and over
- People
- 735 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05947851 · EU 2022-501560-17-00 - Phase 3Taking peopleA Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
- Where
- Albany, Austin, Berkeley, Billings, Boca Raton, Boise, Broomall, Buffalo, Charlotte, Charlottesville, Chattanooga, Clermont, Denver, Edgewood, Edmonds, Fairfax, Florham Park, Fort Myers, Fort Wayne, Fort Worth, Gilbert, Golden, Goldsboro, Grand Junction, Grand Rapids, Hackensack, Iowa City, Issaquah, Kansas City, La Jolla, Madison, Mobile, Nashville, Norwich, Owensboro, Pasadena, Phoenix, Prescott, Richmond, Saint Louis Park, San Antonio, Seattle, Spokane, Tyler, Waukee, West Palm Beach, Williamsville, York
- Age
- 18 years and over
- People
- 1,200 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06136559 · EU 2022-501697-19-01 - Phase 3Taking peopleROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
- Where
- Bethesda, Columbus, Durham, Las Vegas, Pittsburgh, Skokie, Spokane
- Age
- 18 years and over
- People
- 306 worldwide
- Run by
- Newave Pharmaceutical Inc
See details and how to joinNCT07342478 · EU 2026-525656-28-00 - Early phase 1Taking peopleImmune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
- Where
- Bethesda
- Age
- 18 years to 100 years
- People
- 30
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT07428707 - Phase 2Not yet taking people in United StatesNemtabrutinib for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Refractory to Covalent Bruton Tyrosine Kinase Inhibitor or Pirtobrutinib and Previously Treated With a BCL2 Inhibitor
- Where
- Bethesda
- Age
- 18 years to 100 years
- People
- 32
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT07796373 - Phase 2Taking peopleA Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
- Where
- Austin, Blacksburg, Charlottesville, Chicago, Cincinnati, Cleveland, Columbus, Coral Gables, Dallas, Denver, Detroit, Duarte, Durham, Fairfax, Fairfield, Fort Wayne, Indianapolis, Iowa City, Irvine, Los Angeles, Milwaukee, Nashville, Norfolk, Phoenix, Pittsburgh, Salt Lake City, San Diego, San Francisco, Sarasota, Seattle, Silver Spring, Winston-Salem
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT07221500 - Phase 1/2Taking peopleStudy of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
- Where
- Aurora, Belleville, Coral Gables, Eugene, Irvine, Kansas City, Las Vegas, Nashville, Pittsburgh, Tyler
- Age
- 18 years and over
- People
- 150
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT07520006 - Phase 1Taking peopleCD70.CAR for AML and Other CD70+ Leukemias
- Where
- Houston
- Age
- Up to 75 years
- People
- 78
- Run by
- Baylor College of Medicine
See details and how to joinNCT06345027 - Phase 3Taking peopleTesting Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
- Where
- Aberdeen, Adrian, Albuquerque, Allentown, Alton, Ames, Anaconda, Anaheim, Anchorage, Ankeny, Ann Arbor, Antigo, Appleton, Arroyo Grande, Ashland, Auburn, Augusta, Aurora, Baker City, Baldwin Park, Ballwin, Baltimore, Bardstown, Basking Ridge, Baton Rouge, Battle Creek, Beavercreek, Bellevue, Bellflower, Bellingham, Belpre, Bend, Bethesda, Bethlehem, Billings, Birmingham, Bloomington, Boardman, Boiling Springs, Boise, Bolivar, Boone, Boston, Boulder, Bozeman, Brighton, Bristol, Brownstown, Brunswick, Bryan, Burbank, Burien, Burnsville, Burr Ridge, Caldwell, Cambridge, Camden, Cameron Park, Camillus, Canton, Cape Girardeau, Carbondale, Carmichael, Caro, Carroll, Carterville, Carthage, Cedar Rapids, Centennial, Centerville, Centralia, Chadds Ford, Chapel Hill, Charleston, Chelsea, Chesterfield, Cheyenne, Chicago, Chico, Chillicothe, Cincinnati, City of Saint Peters, Clackamas, Clarkston, Cleveland, Clinton, Clinton Township, Clive, Cody, Coeur d'Alene, Collierville, Colorado Springs, Columbus, Commack, Coon Rapids, Coos Bay, Corbin, Costa Mesa, Council Bluffs, Creston, Creve Coeur, Crown Point, Dallas, Damariscotta, Danville, Dayton, Dearborn, Decatur, Deer River, DeKalb, Delaware, Denver, Des Moines, Detroit, Dixon, Duarte, Dublin, Duluth, Durango, Durham, Easley, East China Township, East Stroudsburg, East Syracuse, Eau Claire, Edina, Edinburg, Edmonds, Effingham, Elk Grove, Elmhurst, Emmett, Englewood, Enumclaw, Eureka, Evanston, Everett, Fairbanks, Farmington, Federal Way, Findlay, Flint, Fontana, Fort Dodge, Fort Lauderdale, Fort Smith, Franklin, Fridley, Fruitland, Gahanna, Galesburg, Garden City, Geneva, Glens Falls, Glenview, Golden, Goldsboro, Grand Island, Grand Junction, Grand Rapids, Grayslake, Great Bend, Great Falls, Greeley, Green Bay, Greenville, Greer, Grenada, Grosse Pointe Woods, Grove City, Harbor City, Harrison, Harvey, Hays, Hazleton, Hendersonville, Hibbing, Highland Park, Hillsborough, Homer Glen, Hot Springs, Huntington Beach, Indianapolis, Irvine, Issaquah, Jackson, Jacksonville, Jefferson, Jefferson City, Jersey City, Jonesboro, Joplin, Kalamazoo, Kalispell, Kansas City, Kearney, Kenansville, Kennewick, Kettering, Kewanee, Kingsport, Kinston, Kirkland, Lacey, La Crosse, Lafayette, Laguna Hills, Lake Forest, Lakewood, Lancaster, Lansing, Las Cruces, Las Vegas, Lawrence, Lebanon, Lee's Summit, Lewes, Lexington, Lima, Lincoln, Littleton, Livonia, London, Lone Tree, Long Beach, Long Branch, Longmont, Longview, Los Angeles, Louisville, Loveland, Macomb, Madison, Mansfield, Maple Grove, Maplewood, Marietta, Marion, Marlette, Marshalltown, Marshfield, Marysville, Mattoon, Mayfield Heights, Maywood, Medford, Melrose Park, Memphis, Meridian, Middletown, Millville, Milwaukee, Minneapolis, Minocqua, Missoula, Monroe, Monticello, Montvale, Mount Vernon, Muskegon, Nampa, Naperville, Nashville, New Albany, Newark, Newberg, New Brunswick, New Lenox, New Orleans, Newport Beach, New Richmond, New Ulm, New York, Niles, Norton, Norton Shores, Novi, Oconto Falls, O'Fallon, Oklahoma City, Olathe, Omaha, Ontario, Orange, Oregon City, Orland Park, Oswego, Ottawa, Overland Park, Oxford, Palo Alto, Panorama City, Papillion, Parker, Pekin, Pensacola, Peoria, Perrysburg, Peru, Philadelphia, Phoenix, Pittsburgh, Plainfield, Pontiac, Portland, Portsmouth, Port Townsend, Post Falls, Poulsbo, Princeton, Pueblo, Redmond, Reed City, Rehoboth Beach, Rhinelander, Rice Lake, Richardson, Richlands, Richmond, Rio Rancho, Riverside, Robbinsdale, Rochester, Rockford, Rocklin, Rolla, Sacramento, Saginaw, Saint Cloud, Sainte Genevieve, Saint Joseph, Saint Louis Park, Saint Paul, Salina, Salt Lake City, San Diego, Sandpoint, Sandstone, San Luis Obispo, San Marcos, Santa Maria, Scarborough, Seaford, Seattle, Sedro-Woolley, Seneca, Shakopee, Sheboygan, Shelby, Shelton, Shepherdsville, Sheridan, Shreveport, Silverdale, Southfield, Southhaven, South Pasadena, South Portland, Springfield, Sterling Heights, Stevens Point, Stillwater, St Louis, Stoneham, Sullivan, Sylvania, Syracuse, Tacoma, Tawas City, Thornton, Toledo, Toms River, Topeka, Torrance, Traverse City, Troy, Tucson, Twin Falls, Uniondale, Upland, Urbana, Vancouver, Verona, Virginia, Voorhees Township, Waconia, Walla Walla, Warren, Warrenville, Washington, Washington D.C., Waukee, Wausau, Webster, West Bloomfield, West Branch, West Chester, West Des Moines, Westerville, Weston, Westwood, Wilkes-Barre, Willmar, Willow Grove, Wilmington, Wisconsin Rapids, Woodbury, Woodland, Woodland Hills, Wright-Patterson Air Force Base, Wyandotte, Wyoming, Yakima, Yelm, Yorkville, Youngstown, Ypsilanti, Zanesville
- Age
- 18 years and over
- People
- 247 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04269902 - Phase 1Taking peopleTesting the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
- Where
- Atlanta, Basking Ridge, City of Saint Peters, Columbus, Commack, Creve Coeur, Harrison, Middletown, Mineola, Montvale, New York, Richmond, St Louis, Uniondale
- Age
- 18 years and over
- People
- 30
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04301076 - Phase 2Taking peopleEffects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers
- Where
- Salt Lake City
- Age
- 18 years and over
- People
- 86
- Run by
- University of Utah
See details and how to joinNCT04844528 - Phase 3Taking peopleA Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
- Where
- Bethesda, Bullhead City, Canton, Greenville, Huntington Park, Morrisville, Rockville, St. Petersburg, Wilson
- Age
- 18 years and over
- People
- 386 worldwide
- Run by
- Grifols Therapeutics LLC
See details and how to joinNCT05645107 · EU 2022-502193-16-00 - Phase 3Taking peopleA Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
- Where
- Atlanta, Aurora, Baton Rouge, Bethesda, Billings, Chesterfield, Cleveland, Dayton, Eugene, Fort Myers, Golden, Grand Rapids, Jacksonville, Jonesboro, Los Angeles, Minneapolis, New York, Omaha, Pittsburgh, San Diego, Shirley, Springfield, Syracuse, Temple, Tyler, Westbury, Weston, Whittier, York
- Age
- 18 years and over
- People
- 250 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT06846671 · EU 2024-518893-15-00 - Phase 2Taking peoplePhase II Study of Combined Pirtobrutinib, Venetoclax and Obinutuzumab (PVO) Time-limited Treatment for Patients With Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).
- Where
- Houston
- Age
- 18 years and over
- People
- 40
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06967610 - Phase 2Taking peopleBlinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
- Where
- Houston
- Age
- 18 years and over
- People
- 90
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03263572 - Phase 2Taking peopleVenetoclax Plus Zanubrutinib for the Treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
- Where
- Columbus
- Age
- 18 years and over
- People
- 155
- Run by
- Kerry Rogers
See details and how to joinNCT07734038 - Phase 2Not yet taking people in United StatesEpcoritamab as Consolidation Therapy for High-Risk Pts w/CLL on BTKI
- Where
- Orange
- Age
- 18 years and over
- People
- 24
- Run by
- University of California, Irvine
See details and how to joinNCT07819214 - Phase 2Taking peopleTafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Where
- Duarte, Irvine
- Age
- 18 years and over
- People
- 35
- Run by
- City of Hope Medical Center
See details and how to joinNCT07582159 - Phase 1Taking peopleA Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
- Where
- Columbus, Houston, New York, Rochester, Salt Lake City
- Age
- 18 years and over
- People
- 332 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT05091424 - Phase 2Taking peopleA Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Where
- Aurora, Austin, Bethesda, Boston, Chandler, Duarte, Edgewood, Eugene, Greenville, Gulfport, Hampton, Henderson, Irvine, Miami, Newnan, Palo Alto, The Woodlands, Waukee, York
- Age
- 18 years and over
- People
- 249 worldwide
- Run by
- Loxo Oncology, Inc.
See details and how to joinNCT06588478 · EU 2024-515689-15-01 - Phase 4Taking peopleA Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Where
- Cincinnati, Coon Rapids, Fort Worth, Ithaca, Jacksonville, Kyle, Mobile, New York, Tucson
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07218341 - Phase 3Taking peopleTesting the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
- Where
- Aberdeen, Abilene, Akron, Ames, Anaconda, Anaheim, Ankeny, Ashland, Athens, Avon, Baker City, Baldwin Park, Bellflower, Bemidji, Billings, Birmingham, Bismarck, Bloomington, Boise, Boston, Bozeman, Brainerd, Brighton, Burnsville, Caldwell, Canton, Cape Girardeau, Carroll, Carthage, Cedar Rapids, Chanute, Chapel Hill, Chelsea, Cherry Hill, Chicago, City of Saint Peters, Cleveland, Clive, Coeur d'Alene, Collierville, Colorado Springs, Columbus, Coon Rapids, Coral Gables, Coral Springs, Creve Coeur, Danville, Decatur, Deerfield Beach, Deer River, Delaware, Denver, Des Moines, Detroit, Dixon, Dodge City, Doral, Dublin, Duluth, Durham, Edina, Edmonds, Effingham, El Dorado, Eureka, Fargo, Farmington, Farmington Hills, Fontana, Fort Dodge, Fremont, Fresno, Galesburg, Glens Falls, Grand Junction, Great Falls, Green Bay, Harbor City, Hays, Hendersonville, Hibbing, Hollywood, Honolulu, Independence, Irvine, Issaquah, Jersey City, Jupiter, Kalispell, Kansas City, Kewanee, Kingman, La Crosse, Lafayette, Lakeland, Lansing, Lawrence, Lee's Summit, Liberal, Livingston, Livonia, Lone Tree, Long Branch, Los Angeles, Louisville, Macomb, Madison, Mansfield, Marion, Marshalltown, Mattoon, Mayfield Heights, McPherson, Memphis, Meridian, Miami, Miami Beach, Minneapolis, Missoula, Mitchell, Modesto, Monroe, Mukwonago, Nampa, Newark, Newberg, New Brunswick, Newton, New York, Normal, North Miami, Oakland, Oconomowoc, Oconto Falls, O'Fallon, Oklahoma City, Olathe, Ontario, Oregon City, Ottawa, Overland Park, Panorama City, Parsons, Pekin, Pella, Peoria, Peru, Philadelphia, Pickerington, Pierre, Plantation, Pontiac, Portland, Post Falls, Pratt, Princeton, Providence, Richmond, Riverside, Rochester, Rockford, Roseville, Sacramento, Sainte Genevieve, Saint Louis Park, Saint Paul, Salina, San Diego, Sandpoint, Sandstone, San Francisco, San Jose, San Leandro, San Marcos, San Rafael, Santa Clara, Santa Rosa, Seattle, Sewell, Shiloh, Shreveport, Sioux Falls, Southhaven, South Portland, South San Francisco, Springfield, St Louis, Sturgeon Bay, Sullivan, Tappahannock, Topeka, Urbana, Vallejo, Virginia, Walnut Creek, Washington, Waukee, Waukesha, Webster, Wellington, Westerville, Westwood, Wichita, Wilkes-Barre, Winfield, Woodbury, Woodland Hills, Yankton, Ypsilanti
- Age
- 65 years and over
- People
- 466
- Run by
- Alliance for Clinical Trials in Oncology
See details and how to joinNCT07321652 - Phase 2Taking peoplePersonalized NK Cell Therapy in CBT
- Where
- Houston
- Age
- 15 years to 80 years
- People
- 100
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT02727803